A role for the transcription factor RelB in IFN-α production and in IFN-α-stimulated cross-priming

European Journal of Immunology

Volumn 36, Issue 8, 2006, Pages 2085-2093

  Le Bon, Agnes ^a,c   Montoya, Maria ^a,d   Edwards, Matthew J ^a,e   Thompson, Clare ^a   Burke, Shannon A ^a   Ashton, Miranda ^a   Lo, David ^b   Tough, David F ^a   Borrow, Persephone ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c INSERM   (France)

^d Campus Universitaria Bellaterra ^*  (Spain)

^e NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

Author keywords

Cross priming; IFN ; LCMV; RelB

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEMATOPOIETIC CELL; HETEROZYGOTE; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION; WILD TYPE;

EID: 33747405929     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535228     Document Type: Article

References (35)

1. Ghosh, S., May, M. J. and Kopp, E. B., NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998. 16: 225-260.
2. Sha, W. C., Regulation of immune responses by NF-kappa B/Rel transcription factor. J. Exp. Med. 1998. 187: 143-146.
3. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R. and Lo, D., Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 1995. 373: 531-536.
4. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A. and Bravo, R., Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 1995. 80: 331-340.
5. Xia, Y., Pauza, M. E., Feng, L. and Lo, D., RelB regulation of chemokine expression modulates local inflammation. Am. J. Pathol 1997. 151: 375-387
6. Naspetti, M., Aurrand-Lions, M., DeKoning, J., Malissen, M., Galland, F., Lo, D. and Naquet, P., Thymocytes and RelB-dependent medullary epithelial cells provide growth-promoting and organization signals, respectively, to thymic medullary stromal cells. Eur. J. Immunol. 1997. 27: 1392-1397.
7. Weih, D. S., Yilmaz, Z. B. and Weih, F., Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 2001. 167: 1909-1919.
8. Gerloni, M., Lo, D. and Zanetti, M., DNA immunization in RelB-deficient mice discloses a role for dendritic cells in IgM->IgG1 switch in vivo. Eur. J. Immunol. 1998. 28: 516-524.
9. Snapper, C. M., Rosas, F. R., Zelazowski, P., Moorman M. A., Kehry, M. R., Bravo, R. and Weih, F., B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 1996. 184: 1537-1541.
10. Elewaut, D., Shaikh R. B., Hammond, K. J., De Winter, H., Leishman, A. J., Sidobre, S., Turovskaya, O. et al., NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J. Exp. Med. 2003. 197. 1623-1633.
11. Weih, F., Warr, G., Yang, H. and Bravo, R., Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 1997 158: 5211-5218.
12. Caamano, J., Alexander, J., Craig, L., Bravo, R. and Hunter, C. A., The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 1999. 163: 4453-4461.
13. Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman K., CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol 2000. 164: 2978-2986.
14. + dendritic cells are generally involved in priming CTL immunity to vinises. J. Immunol 2004. 172: 1996-2000.
15. Heath, W. R., Belz, G. T., Behrens, G. M., Smith, C. M., Forehan S. P., Parish, I. A., Davey, G. M. et al., Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 2004. 199: 9-26.
16. Lanzavecchia, A., Immunology. Licence to kill. Nature 1998. 393: 413-414.
17. den Haan J. M., Lehar, S. M. and Bevan, M. J., CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000. 192: 1685-1696.
18. Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A. et al., Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001. 2: 1144-1150.
19. Dalod, M., Salazar-Mather, T. P., Malmgaard, L., Lewis, C., Asselin-Paturel, C., Briere, F., Trinchieri, G. and Biron, C. A., Interferon alpha/ beta and interleukin 12 responses to viral infections: Pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 2002. 195: 517-528.
20. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D. F., Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001. 14: 461-470.
21. Le Bon, A. and Tough, D. F., Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002. 14: 432-436.
22. + T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003. 4: 1009-1015.
23. + dendritic cells. Immunity 1998. 9: 839-847.
24. Castiglioni, P., Janssen, E. M, Prilliman, K. R., Gerloni, M., Schoenberger, S. and Zanetti, M., Cross-priming is under control of the relB gene. Scand. J. Immunol. 2002. 56: 219-223.
25. Mintern, J. D., Belz, G., Gerondakis, S., Carbone, F. R. and Heath, W. R., The cross-priming APC requires a Rel-dependent signal to induce CTL. J. Immunol. 2002.168: 3283-3287
26. Montoya, M., Edwards, M. J., Reid, D. M. and Borrow, P., Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: Analysis of the involvement of type 1 IFN. J. Immunol. 2005. 174: 1851-1861.
27. Murali-Krishna, FL, Altman J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. and Ahmed, R., Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998. 8: 177-187.
28. Muller, U., Steinhoff, U., Reis, L. F., Hemmi S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science 1994. 264: 1918-1921.
29. Ou, R., Zhou, S., Huang, L. and Moskophidis, D., Critical role for alpha/ beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 2001. 75: 8407-8423.
30. Honda, K., Yanai, H., Takaoka, A. and Taniguchi, T., Regulation of the type 1 IFN induction: A current view. Int. Immunol. 2005. 17: 1367-1378.
31. Probst, H. C. and van den Broek, M., Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 2005. 174: 3920-3924.
32. + dendritic cells but not by Langerhans cells. Science 2003. 301: 1925-1928.
33. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 2003. 170: 4437-4440.
34. Lo, D., Quill, H., Burkly, L., Scott, B., Palmiter, R. D. and Brinster, R. L., A recessive defect in lymphocyte or granulocyte function caused by an integrated transgene. Am. J. Pathol. 1992. 141: 1237-1246.
35. Dutko, F. J. and Oldstone, M. B., Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 1983. 64: 1689-1698.